30.11.2021 03:06:35
|
CDC Strengthens Booster Recommendation For All Adults Due To Omicron Variant Concerns
(RTTNews) - The U.S. Centers for Disease Control and Prevention has strengthened its recommendation for COVID-19 booster shots for all U.S. adults amid growing concern about the new omicron variant. The agency previously said all adults may get the booster shot.
The CDC said Monday that everyone ages 18 and older in U.S. should get a booster shot either when they are 6 months after their initial Pfizer or Moderna series or 2 months after their initial Johnson & Johnson vaccine.
"The recent emergence of the Omicron variant (B.1.1.529) further emphasizes the importance of vaccination, boosters, and prevention efforts needed to protect against COVID-19," CDC Director Rochelle Walensky said in a statement.
The CDC stated that the early data from South Africa suggested increased transmissibility of the Omicron variant, and scientists in the United States and around the world are urgently examining vaccine effectiveness related to this variant.
Walensky has asked the 47 million U.S. adults who are not yet vaccinated to get vaccinated as soon as possible and to vaccinate the children and teens in their families as well because strong immunity will likely prevent serious illness.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Johnson & Johnsonmehr Nachrichten
17.12.24 |
NYSE-Handel Dow Jones am Dienstagnachmittag mit Abgaben (finanzen.at) | |
17.12.24 |
Dow Jones-Handel aktuell: Dow Jones fällt (finanzen.at) | |
16.12.24 |
Schwacher Handel in New York: Dow Jones schlussendlich in Rot (finanzen.at) | |
11.12.24 |
Angespannte Stimmung in New York: Dow Jones beendet die Mittwochssitzung im Minus (finanzen.at) | |
11.12.24 |
Schwache Performance in New York: Dow Jones notiert nachmittags im Minus (finanzen.at) | |
11.12.24 |
Zuversicht in New York: Dow Jones mit Kursplus (finanzen.at) | |
11.12.24 |
Dow Jones 30 Industrial-Titel Johnson Johnson-Aktie: So viel hätten Anleger mit einem Investment in Johnson Johnson von vor 10 Jahren verdient (finanzen.at) | |
11.12.24 |
Schwacher Wochentag in New York: Dow Jones zum Start des Mittwochshandels in der Verlustzone (finanzen.at) |
Analysen zu Johnson & Johnsonmehr Analysen
Aktien in diesem Artikel
BioNTech (ADRs) | 111,40 | -0,71% | |
Johnson & Johnson | 139,36 | 0,39% | |
Moderna Inc | 38,41 | -1,32% | |
Pfizer Inc. | 25,16 | 0,34% |